Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

White blood cell differential counts in patients with polycystic ovary syndrome: a pilot study on Chinese women.

Shi Y, Han T, Cui L, Wu G, Zheng R, Xia M, Chen ZJ.

Eur J Obstet Gynecol Reprod Biol. 2013 Sep;170(1):162-4. doi: 10.1016/j.ejogrb.2013.06.002. Epub 2013 Jun 29.

PMID:
23820138
2.
3.

Association between inflammatory biomarker serum procalcitonin and obesity in women with polycystic ovary syndrome.

Rashad NM, El-Shal AS, Abdelaziz AM.

J Reprod Immunol. 2013 Apr;97(2):232-9. doi: 10.1016/j.jri.2012.10.007. Epub 2012 Dec 4.

PMID:
23218400
4.

White blood cells levels and PCOS: direct and indirect relationship with obesity and insulin resistance, but not with hyperandogenemia.

Papalou O, Livadas S, Karachalios A, Tolia N, Kokkoris P, Tripolitakis K, Diamanti-Kandarakis E.

Hormones (Athens). 2015 Jan-Mar;14(1):91-100. doi: 10.14310/horm.2002.1563.

5.

Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.

Guzelmeric K, Alkan N, Pirimoglu M, Unal O, Turan C.

Gynecol Endocrinol. 2007 Sep;23(9):505-10.

PMID:
17852421
6.

Plasma selenium levels in Turkish women with polycystic ovary syndrome.

Coskun A, Arikan T, Kilinc M, Arikan DC, Ekerbiçer HÇ.

Eur J Obstet Gynecol Reprod Biol. 2013 Jun;168(2):183-6. doi: 10.1016/j.ejogrb.2013.01.021. Epub 2013 Mar 13.

PMID:
23490536
7.

Relationship of GnRH-stimulated LH release to episodic LH secretion and baseline endocrine-metabolic measures in women with polycystic ovary syndrome.

Patel K, Coffler MS, Dahan MH, Malcom PJ, Deutsch R, Chang RJ.

Clin Endocrinol (Oxf). 2004 Jan;60(1):67-74.

PMID:
14678290
8.
9.

Polycystic ovary syndrome: relationship between insulin sensitivity, sex hormone levels and ovarian stromal blood flow.

Loverro G, Vicino M, Lorusso F, Vimercati A, Greco P, Selvaggi L.

Gynecol Endocrinol. 2001 Apr;15(2):142-9.

PMID:
11379011
10.

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.

Arikan S, Bahceci M, Tuzcu A, Kale E, Gökalp D.

Gynecol Endocrinol. 2010 Mar;26(3):161-6. doi: 10.3109/09513590903247816.

PMID:
20148738
11.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

PMID:
15802325
12.

A macrophage activation marker chitotriosidase in women with PCOS: does low-grade chronic inflammation in PCOS relate to PCOS itself or obesity?

Alanbay I, Ercan CM, Sakinci M, Coksuer H, Ozturk M, Tapan S.

Arch Gynecol Obstet. 2012 Oct;286(4):1065-71. doi: 10.1007/s00404-012-2425-0. Epub 2012 Jun 21.

PMID:
22718099
13.

Prevalence of an immunological LH beta-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome.

Rajkhowa M, Talbot JA, Jones PW, Pettersson K, Haavisto AM, Huhtaniemi I, Clayton RN.

Clin Endocrinol (Oxf). 1995 Sep;43(3):297-303.

PMID:
7586598
14.

Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).

Kumar A, Woods KS, Bartolucci AA, Azziz R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):644-9.

PMID:
15943823
15.

[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].

Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.

Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23. Bulgarian.

PMID:
24294740
16.

Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.

Thomann R, Rossinelli N, Keller U, Tirri BF, De Geyter C, Ruiz J, Kränzlin M, Puder JJ.

Gynecol Endocrinol. 2008 Apr;24(4):199-206. doi: 10.1080/09513590801893398.

PMID:
18382906
17.

Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.

Baranowska B, Radzikowska M, Wasilewska-Dziubińska E, Kapliński A, Roguski K, Płonowski A.

Gynecol Endocrinol. 1999 Oct;13(5):344-51.

PMID:
10599552
18.

Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters.

Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N.

Clin Endocrinol (Oxf). 2001 Apr;54(4):447-53.

PMID:
11318779
19.

The effect of obesity on inflammatory markers in patients with PCOS: a BMI-matched case-control study.

Keskin Kurt R, Okyay AG, Hakverdi AU, Gungoren A, Dolapcioglu KS, Karateke A, Dogan MO.

Arch Gynecol Obstet. 2014 Aug;290(2):315-9. doi: 10.1007/s00404-014-3199-3. Epub 2014 Mar 19.

PMID:
24643802
20.

Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.

Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.

Clin Endocrinol (Oxf). 2007 Jan;66(1):103-9.

PMID:
17201808

Supplemental Content

Support Center